Endothelial cell function alteration after Junin virus infection
- 1 January 2003
- journal article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 90 (08) , 326-334
- https://doi.org/10.1160/th02-09-0043
Abstract
Hematologic involvement is the main feature of Argentine hemorrhagic fever (AHF), an endemo-epidemic disease caused by Junin virus (JV). Since endothelial dysfunction could play a role in AHF-altered hemostasis, we studied human umbilical vein endothelial cell (HUVEC) infection with a virulent (JVv) and a non-virulent (JVa) JV strain. Cells were infected by the two JV variants with no detectable apoptosis or cytopathic effect. Both viral variants up-regulated ICAM-1 and VCAM-1 levels, while von Willebrand factor (VWF) production was decreased. Prostacyclin (PGI2) release and decay accelerating factor (DAF) expression were greater in JVv- than in JVa-infected or control cells. Furthermore, nitric oxide (NO) production and endothelial nitric oxide synthase (eNOS) expression was only raised in JVv-infected supernatants. Significant NO and PGI2 values were also detected in AHF patient sera. These data demonstrate that endothelial cell responses are triggered subsequently by JV infection, suggesting that such alterations play a major role in the pathogenesis of AHF and perhaps in other viral-induced hemorrhagic diseases.Keywords
Funding Information
- René Baron Foundation
This publication has 37 references indexed in Scilit:
- Human Endothelium as a Source of Multifunctional Cytokines: Molecular Regulation and Possible Role in Human DiseaseJournal of Interferon & Cytokine Research, 1999
- VEGF-A Induces Expression of eNOS and iNOS in Endothelial Cells via VEGF Receptor-2 (KDR)Biochemical and Biophysical Research Communications, 1998
- BIOCHEMISTRY AND GENETICS OF VON WILLEBRAND FACTORAnnual Review of Biochemistry, 1998
- Altered expression of host‐encoded complement regulators on human cytomegalovirus‐infected cellsEuropean Journal of Immunology, 1996
- Antiviral treatment of argentine hemorrhagic feverAntiviral Research, 1994
- A plasma inhibitor of platelet aggregation in patients with Lassa feverBritish Journal of Haematology, 1989
- Molecular Cloning of the Complementary DNA for Human Tumor Necrosis FactorScience, 1985
- IMPORTANCE OF DOSE OF NEUTRALISING ANTIBODIES IN TREATMENT OF ARGENTINE HAEMORRHAGIC FEVER WITH IMMUNE PLASMAThe Lancet, 1984
- Argentine Hemorrhagic FeverNew England Journal of Medicine, 1978
- Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIAJournal of Clinical Investigation, 1973